Average Co-Inventor Count = 8.58
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (12 from 116 patents)
2. Abbvie S.a.r.l. (7 from 15 patents)
3. Abbott Laboratories Corporation (6 from 4,177 patents)
4. Abbvie Overseas Sarl (5 from 5 patents)
5. Abbvie Inc. (2 from 822 patents)
6. Abbvie Global Enterprises Ltd. (1 patent)
20 patents:
1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
3. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
4. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
6. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
7. 10399940 - Substituted pyrrolidines and methods of use
8. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein
9. 9981910 - Substituted pyrrolidines and methods of use
10. 9840513 - Substituted tricyclics and method of use
11. 9642831 - Substituted chromanes and method of use
12. 9567322 - Substituted tetrahydropyrans and method of use
13. 8796470 - Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators
14. 8691865 - Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
15. 8129417 - Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers